ALL THOSE PRICKS were worth a fortune to drug company shareholders. Before the COVID pandemic hit, the price of a Pfizer
share was about $35 in January, 2000. Now two years later, it’s hovering around $55. Had you bought a modest 100 shares for $3,500 it would now be worth $5,500, a return on investment of 57 per cent. And the vaccines and profits keep on flowing.